ISRCTN88392614已完成不适用
Phase change material to treat Buruli ulcer through heat treatment: a prospective observational single centre proof-of-principle study
niversity Hospital Heidelberg (Universitätsklinikum Heidelberg) (Germany)0 个研究点目标入组 10 人开始时间: 2008年8月29日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Patients (male and female) aged 6 - 21 years
- •2. Single ulcer clinically diagnosed as Buruli ulcer (WHO 2001)
- •3. Laboratory confirmation of Buruli ulcer: on day 0 four swabs from the undermined edges and one diagnostic biopsy from all patients enrolled into the trial on clinical grounds are taken. All samples are investigated by microscopy for acid-fast bacilli (AFB) after Ziehl Neelsen (ZN) staining and by IS2404 real-time polymerase chain reaction (PCR). Histopathological changes typical for BU are recorded.
排除标准
- •In view of the unproblematic nature of the treatment no relevant adverse effects are foreseen. Nevertheless, patients with significant underlying other communicable and non-communicable diseases are excluded in this first proof-of-principle study.
研究者
相似试验
已完成
2 期
BURULICO Drug Trial Study Protocol: RCT SR8/SR4+CR4, GHANABuruli UlcerMycobacterium UlceransNCT00321178University Medical Center Groningen151
暂停
不适用
PRP for intractable ulcersIntractable ulcersJPRN-jRCTc070190058Rikimaru Hideaki20
尚未招募
3 期
Shortening Buruli Ulcer treatment: WHO recommended vs. a novel beta-lactam-containing therapy - Phase III evaluation in West AfricaPACTR202209521256638niversity of Zaragoza174
招募中
不适用
Adjuvant therapy of severe and/or refractory bullous pemphigoids with immunoadsorption by LIGASORB®, dapsone, prednisolone and topical mometasone fumarate (LiBPem-Study).L12.0Bullous pemphigoidDRKS00013775niversitätsklinikum Schleswig-Holstein Campus Lübeck10
已完成
不适用
Treatment of cutaneous ulcer using platelet-rich plasmacutaneous ulcerJPRN-UMIN000009860ational Center for Global Health and Medicine20